Jean Bismuth, MD
Vascular Surgery · Houston, TXNPI 1639330053
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 36.2% of the total. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $548.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$88K
- Penumbra, Inc.$83K
- Cook Incorporated$22K
- Philips North America LLC$19K
- GE HealthCare$14K
- Johnson & Johnson$6K
- plus $11K from 32 others
Across 3 payments — averaging $46,282 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$84K
- W. L. Gore & Associates, Inc.$55K
What the payments were for
- Consulting fees$45,91619%
- Speaking & faculty fees$133,01555%
- Travel & lodging$39,34016%
- Food & beverage$24,47210%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 157 | $87,858 |
| Penumbra, Inc. | 90 | $83,023 |
| Cook Incorporated | 7 | $22,290 |
| Philips North America LLC | 22 | $19,106 |
| GE HealthCare | 8 | $13,631 |
| Johnson & Johnson(3 entities) | 10 | $6,296 |
| Cook Medical LLC | 75 | $4,128 |
| Boston Scientific | 14 | $2,778 |
| Medtronic(2 entities) | 8 | $596 |
| Shockwave Medical, Inc | 4 | $352 |
| Silk Road Medical, Inc. | 8 | $292 |
| Avinger Inc. | 3 | $232 |
| Baxter Healthcare | 2 | $204 |
| Heartflow, Inc. | 2 | $184 |
| Wound Management Technologies, Inc | 3 | $178 |
| Surmodics, Inc. | 2 | $167 |
| Biom'up France SAS | 1 | $151 |
| Sanara Medtech Inc. | 4 | $148 |
| Kerecis Limited | 1 | $132 |
| Abbott | 1 | $120 |
| Livanova USA, Inc. | 1 | $119 |
| Merit Medical Systems Inc | 1 | $110 |
| Stryker | 1 | $95 |
| Angiodynamics, Inc. | 1 | $93 |
| Endologix LLC | 2 | $76 |
| Cvrx, Inc. | 2 | $74 |
| Tactile Systems Technology Inc | 2 | $73 |
| Artivion, Inc. | 1 | $58 |
| Medical Device Business Services, Inc. | 1 | $54 |
| Bolton Medical Inc | 1 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $26 |
| Elutia, Inc. | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| CSL Behring | 1 | $16 |
| Amgen | 1 | $15 |
| Pfizer | 1 | $15 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$75,811
- Conformable TAG Thoracic Endoprosthesis$18,122
- Zilver PTX$13,568
- ALLIA$13,068
- GORE VIABAHN VBX Balloon Expandable Endo$12,450
- VIABAHN Endoprosthesis$11,563
- VIABAHN VBX Balloon Expandable Endoprosthesis$10,704
- IGT Enabling functio$10,493
- Product in Development$8,347
- EXCLUDER Iliac Branch Endoprosthesis$7,700
- Cook$6,745
- EXCLUDER AAA Endoprosthesis$6,093
- RUBY Coil$5,842
- Ultrasound Enabling Functions$5,142
- GORE VIABAHN Endoprosthesis$4,845
- GORE VIABAHN Endoprosthesis with Heparin$4,703
- CLINICAL TRIAL PRODUCT$2,490
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$1,853
- Cook Medical Peripheral Intervention$1,720
- DI Und Service$1,500
How this compares
$242,792 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $150 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Houston
- Alan LumsdenHouston$742K
- Gustavo OderichHouston$319K
- Ali AzizzadehHouston$181K
- Steven MaximusHouston$140K
- Samuel LeonardHouston$96K
- Charudatta BavareHouston$72K
- Philip AuyangHouston$43K
- Jayer ChungHouston$42K
- Rana AfifiHouston$41K
- Linda leHouston$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.